Adherence to tyrosine kinase inhibitor therapy for chronic myeloid leukemia: a Brazilian single-center cohort.

@article{Almeida2013AdherenceTT,
  title={Adherence to tyrosine kinase inhibitor therapy for chronic myeloid leukemia: a Brazilian single-center cohort.},
  author={Maria Helena Morgani de Almeida and K{\'a}tia B{\'o}rgia Barbosa Pagnano and Afonso Celso Vigorito and Irene GH Lorand-Metze and C{\'a}rmino Ant{\^o}nio de Souza},
  journal={Acta haematologica},
  year={2013},
  volume={130 1},
  pages={16-22}
}
The introduction of oral tyrosine kinase inhibitors (TKIs) has dramatically improved outcomes in chronic myeloid leukemia (CML) patients. However, treatment success is directly related to good long-term adherence. Adherence to TKI therapy was evaluated in 137 CML patients over a period of 1 year. Three different methods were used to evaluate adherence: the… CONTINUE READING